These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30352709)

  • 21. Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders.
    Nou-Fontanet L; Nguyen QTR; Bachoud-Levi AC; Reinhard C; ; Ortigoza-Escobar JD
    Eur J Paediatr Neurol; 2024 Jul; 51():110-117. PubMed ID: 38917695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
    Gras D; Jonard L; Roze E; Chantot-Bastaraud S; Koht J; Motte J; Rodriguez D; Louha M; Caubel I; Kemlin I; Lion-François L; Goizet C; Guillot L; Moutard ML; Epaud R; Héron B; Charles P; Tallot M; Camuzat A; Durr A; Polak M; Devos D; Sanlaville D; Vuillaume I; Billette de Villemeur T; Vidailhet M; Doummar D
    J Neurol Neurosurg Psychiatry; 2012 Oct; 83(10):956-62. PubMed ID: 22832740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
    Micozkadioglu H; Ozdemir FN; Kut A; Sezer S; Saatci U; Haberal M
    Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 26. Higher prevalence of restless legs syndrome/Willis-Ekbom disease in multiple sclerosis patients is related to spinal cord lesions.
    Minár M; Petrleničová D; Valkovič P
    Mult Scler Relat Disord; 2017 Feb; 12():54-58. PubMed ID: 28283108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Restless legs].
    Kinge E; Lossius MI
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):25-7. PubMed ID: 14716387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of idiopathic and uremic restless legs syndrome].
    Trenkwalder C; Stiasny K; Oertel WH
    Nervenarzt; 1996 Apr; 67(4):265-76. PubMed ID: 8684504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restless legs syndrome: treatment with dopaminergic agents.
    Comella CL
    Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [L-dopa, dopamine agonists, opiates... what calms down restless legs].
    Wepner U
    MMW Fortschr Med; 2005 Feb; 147(8):6, 8. PubMed ID: 18437857
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine dysregulation syndrome in a patient with restless legs syndrome.
    Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I
    Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.
    Tribl GG; Asenbaum S; Klösch G; Mayer K; Bonelli RM; Auff E; Zeitlhofer J; Happe S
    Neurology; 2002 Aug; 59(4):649-50. PubMed ID: 12196677
    [No Abstract]   [Full Text] [Related]  

  • 33. THE RESTLESS LEGS SYNDROME (REVIEW).
    Japaridze G; Kasradze S; Maisuradze L; Popp R; Wetter T
    Georgian Med News; 2018 Dec; (285):74-81. PubMed ID: 30702074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients.
    Shetty VB; Kiraly-Borri C; Lamont P; Bikker H; Choong CS
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):373-8. PubMed ID: 24129101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADCY5 mutations are another cause of benign hereditary chorea.
    Mencacci NE; Erro R; Wiethoff S; Hersheson J; Ryten M; Balint B; Ganos C; Stamelou M; Quinn N; Houlden H; Wood NW; Bhatia KP
    Neurology; 2015 Jul; 85(1):80-8. PubMed ID: 26085604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patient complains about sleep disorders: place "restless legs" therein].
    Eisensehr I; Karlbauer G; Storck K
    MMW Fortschr Med; 2005 Oct; 147(43):62-3. PubMed ID: 16302428
    [No Abstract]   [Full Text] [Related]  

  • 38. NKX2.1 run-on mutation associated to familial brain-lung-thyroid syndrome.
    Cavaliere E; Gortan AJ; Passon N; Fabbro D; Marin D; Carecchio M; Baldan F; Credendino SC; Gallo R; Cogo P; Damante G; De Vita G
    Clin Genet; 2021 Jul; 100(1):114-116. PubMed ID: 33778944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex Ligation-dependent Probe Amplification improves the detection rate of NKX2.1 mutations in patients affected by brain-lung-thyroid syndrome.
    Teissier R; Guillot L; Carré A; Morandini M; Stuckens C; Ythier H; Munnich A; Szinnai G; de Blic J; Clement A; Leger J; Castanet M; Epaud R; Polak M
    Horm Res Paediatr; 2012; 77(3):146-51. PubMed ID: 22488412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of two novel mutations in TTF-1/NKX2.1 homeodomain in patients with benign hereditary chorea.
    Provenzano C; Zamboni M; Veneziano L; Mantuano E; Garavaglia B; Zorzi G; Pagonabarraga J; Giunti P; Civitareale D
    J Neurol Sci; 2016 Jan; 360():78-83. PubMed ID: 26723978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.